NeuroSense Therapeutics
NRSN • NASDAQ
NeuroSense Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Alon Ben-Noon, with a market cap of $28.8M.
CEOAlon Ben-Noon
Next Earnings
Upcoming earnings announcement for NeuroSense Therapeutics
Date
Monday, April 6, 2026 (in 2 months)
Timing
After Market Close (5:00 PM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.04
Earnings History
Past 11 earnings reports for NeuroSense Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Aug 1, 2025 | H1 2025 | -$0.19Est: -$0.13 | -46.2% | - | — | — |
| Apr 7, 2025 | Q4 2024 | -$0.06 | — | - | — | — |
| Dec 18, 2024 | Q3 2024 | -$0.11Est: -$0.16 | +31.3% | - | — | — |
| Sep 30, 2024 | Q2 2024 | -$0.02Est: -$0.20 | +90.0% | - | — | — |
| Jun 24, 2024 | Q1 2024 | -$0.35Est: -$0.20 | -75.0% | - | — | — |
| Apr 5, 2024 | Q4 2023 | -$0.16Est: -$0.23 | +30.4% | - | — | — |
| Nov 28, 2023 | Q3 2023 | $0.10 | — | - | — | — |
| Aug 16, 2023 | Q2 2023 | -$0.44 | — | - | — | — |
| Jun 1, 2023 | Q1 2023 | -$0.33 | — | - | — | — |
| Mar 22, 2023 | Q4 2022 | -$0.27 | — | - | — | — |
| Dec 1, 2022 | Q3 2022 | -$0.25 | — | - | — | — |